NJ State Employees Deferred Compensation Plan - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$226,440
-17.2%
6,0000.0%0.03%
-12.8%
Q2 2023$273,360
+12.3%
6,0000.0%0.04%
+2.6%
Q1 2023$243,360
-20.4%
6,0000.0%0.04%
-22.4%
Q4 2022$305,820
-5.3%
6,0000.0%0.05%
-10.9%
Q3 2022$323,000
-16.1%
6,0000.0%0.06%
-12.7%
Q2 2022$385,000
-17.2%
6,0000.0%0.06%0.0%
Q1 2022$465,000
-9.7%
6,0000.0%0.06%
-3.1%
Q4 2021$515,000
+6.6%
6,0000.0%0.06%
-1.5%
Q3 2021$483,0000.0%6,0000.0%0.07%
+3.1%
Q2 2021$483,000
-4.5%
6,0000.0%0.06%
-11.1%
Q1 2021$506,000
+5.2%
6,0000.0%0.07%
-2.7%
Q4 2020$481,000
-0.4%
6,0000.0%0.07%
-14.9%
Q3 2020$483,000
-6.6%
6,0000.0%0.09%
-10.3%
Q2 2020$517,000
+6.2%
6,0000.0%0.10%
-12.6%
Q1 2020$487,000
-3.0%
6,0000.0%0.11%
+30.6%
Q4 2019$502,000
-4.4%
6,0000.0%0.08%
-11.5%
Q3 2019$525,000
+6.9%
6,0000.0%0.10%
+9.1%
Q2 2019$491,000
+0.6%
6,0000.0%0.09%
-1.1%
Q1 2019$488,000
-42.2%
6,000
-70.0%
0.09%
-50.6%
Q1 2016$844,000
+10.6%
20,0000.0%0.18%
+14.6%
Q4 2015$763,000
+16.1%
20,0000.0%0.16%
+10.6%
Q3 2015$657,000
-53.0%
20,0000.0%0.14%
-47.8%
Q2 2015$1,399,000
+2.1%
20,0000.0%0.27%
+2.6%
Q1 2015$1,370,000
-6.5%
20,0000.0%0.26%
-7.3%
Q4 2014$1,466,000
+2.2%
20,0000.0%0.29%
-2.1%
Q3 2014$1,435,000
-0.8%
20,0000.0%0.29%
+2.1%
Q2 2014$1,446,000
-1.8%
20,0000.0%0.29%
-5.3%
Q1 2014$1,472,00020,0000.30%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders